| ID | Sequence | Length | GC content |
|---|---|---|---|
| GUCUUCUCUCUCUCUCUCCCACUUUUCCUCCCUCUCCCGCUCCGUCUCA… | 7428 nt | 0.4281 | |
| GAUGCGGGCGCUCUCGGCGCACAGCGCGCGGCGCUCCUGCUCCCCGGCG… | 7670 nt | 0.4426 | |
| AUUCCAGAACAGGAGGCAUGAGCCCGGAACGCGCUUGCUUUUAGGAGAC… | 7086 nt | 0.4229 | |
| GAUGCGGGCGCUCUCGGCGCACAGCGCGCGGCGCUCCUGCUCCCCGGCG… | 7699 nt | 0.4408 | |
| AGAAGUCGAUAAGACCAGGAGAAGUGAAGAUGUAACAUGUUAUCUGUCG… | 7200 nt | 0.4231 | |
| UGCUAACAUUGGCUUCAGCUUCCAGUGCAGUUGUGCUGCUGCAUAUAAC… | 7319 nt | 0.4195 |
This gene encodes a member of the myeloid translocation gene family which interact with DNA-bound transcription factors and recruit a range of corepressors to facilitate transcriptional repression. The t(8;21)(q22;q22) translocation is one of the most frequent karyotypic abnormalities in acute myeloid leukemia. The translocation produces a chimeric gene made up of the 5'-region of the runt-related transcription factor 1 gene fused to the 3'-region of this gene. The chimeric protein is thought to associate with the nuclear corepressor/histone deacetylase complex to block hematopoietic differentiation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2010]
A study in human menstrual blood-derived stem cells (MenSCs) demonstrated that the RUNX1T1 was identified as a differentially-expressed gene down-regulated with increasing passage number [Chen et al. DOI:PMC4713568]. In a separate review of RNA sequencing technologies, the RUNX1–RUNX1T1 fusion gene is noted for its diagnostic use in acute myeloid leukemia [Li et al. DOI:10.1038/s41368-021-00146-0].